Exablate 4000
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Exablate 4000, covering 2026-03-20 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications